CH
CRL icon

Cromwell Holdings’s Charles River Laboratories CRL Stock Holding History

Cromwell Holdings’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42K Buy
185
+5
+3% +$890 0.02% 514
2026
Q1 		$31.1K Hold
180
– – 0.02% 525
2025
Q4 		$35.9K Hold
180
– – 0.02% 511
2025
Q3 		$28.2K Hold
180
– – 0.02% 553
2025
Q2 		$27.3K Buy
180
+152
+543% +$20.3K 0.02% 543
2025
Q1 		$4.21K Sell
28
-39
-58% -$6.54K ﹤0.01% 607
2024
Q4 		$12.4K Sell
67
-80
-54% -$15.4K 0.01% 597
2024
Q3 		$29K Hold
147
– – 0.02% 542
2024
Q2 		$30.4K Buy
+147
New +$33.3K 0.02% 529

Other funds holding CRL

CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
CPCPP
Canada Post Corporation Pension Plan Toronto, Canada $2.87B AUM 37.96% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
CCMINC
Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $826M AUM 32.06% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Cromwell Holdings's CRL Position: Q2 2026 in Review

Cromwell Holdings increased its Charles River Laboratories (CRL) stake by 2.8% in Q2 2026, buying an estimated $890 and bringing the position to 185 shares worth $42K. The position accounts for 0.02% of the portfolio, ranked #514.

Cromwell Holdings first reported a position in CRL in Q2 2024 and has held it in 9 quarters since. 82 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Cromwell Holdings held 185 shares of Charles River Laboratories worth $42K as of Q2 2026.
  • Cromwell Holdings bought 5 Charles River Laboratories shares in Q2 2026, an estimated $890.
  • Charles River Laboratories made up 0.02% of Cromwell Holdings's portfolio in Q2 2026, its #514 holding.
  • Cromwell Holdings first reported a position in Charles River Laboratories in Q2 2024 and has held it in 9 quarters since.
  • 82 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.